$HIPH-New Press Release today! #CBD, Sales $169,313 4th

New Post Public Reply Private Reply Replies (0) Message Board
stockstein
387
$HIPH-New Press Release today! #CBD, Sales $169,313 4th quarter!! $HIPH alot of good news lately. Currently cheap shares in my opinion wont be around forever.



American Premium Water Corp. (OTC:HIPH) Announces Subsidiary Gents Q4 Revenue of $169,313
GlobeNewswire•April 3, 2018

PLAYA VISTA, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- American Premium Water Corporation (OTC Pink:HIPH) (the “Company”) announces that its Gents subsidiary posted revenue of $169,313 in the fourth quarter of 2017, exceeding the 600-700% guidance provided last week, with a 150,000% increase in revenues over the same period last year (Q4 17’-Q4 16’). The Gents results will propel the Company to over a 400% year over year increase in top-line revenue. The 2017 year-end report will be released later this week.

Ryan Fishoff, CEO American Premium Water Corporation commented: “I am happy to report to our shareholders that Gents financial performance in Q4 beat even internal expectations. I was a bit conservative with guidance last week, but even I am blown away with the results. We had a good holiday selling season; same store sales were up compared to last year for our department store partners. We have seen progress from a number of initiatives we began in Q1 and I am optimistic that the momentum will continue through 2018. We will be releasing full year end results for the Company by end of the week and I am confident, with the addition of Gents, the Company guidance increases to roughly 400% year over year revenue growth from 2017.”

“The Gents acquisition has already been successful for the Company. In addition to the revenue it has brought in, the Gents team has brought expertise in marketing and branding, as well as logistical & distribution support that will be utilized going forward as we ramp up the sales and distribution of LALPINA beverages. The intellectual capital acquired from Gents will be critical to for the Company to achieve its goals in the near and long term,” added Mr. Fishoff

Gents (www.gentsco.com) is sold in over 200 luxury retail outlets, including Bloomingdales, Saks Fifth Avenue, and Nordstroms. The brand, founded in 2012, focuses on men’s accessories, and has created a niche as being the first brand to focus on luxury baseball caps. The brand recently announced a joint venture with Zhangjiagang Advanced Company, a Chinese company that will begin distributing Gents products into mainland China. In addition to expanding geographically, Gents is looking to add product categories in 2018, leveraging its distribution network for accretive revenue.

“Gents provides tremendous growth potential for the Company. It’s a great brand that has broad appeal. The Company is in a position to invest in the brand, and diversifying the product offerings is a key part of this strategy. There are 35 registered trademarks for Gents. I want to start leveraging them. Apparel is one area that we are going to aggressively pursue. Men’s grooming is another that I see lots of potential for. I’ve also had exploratory discussions with CBD producers about incorporating CBD into topical skin creams. From my research in the market, I have not seen any products like this in the men’s luxury marketplace, and this could be a real niche category for us. These are all things to consider as we evaluate how to invest the capital we are raising from the Reg A (Regulation 1/A) we recently submitted for review,” Mr. Fishoff commented.

The Company submitted a 1/A filing to the Securities and Exchange Commission for review on March 26th. The Company is awaiting feedback and comments before the offering is effective, which at that point will determine the offering price and number of shares to be issued. The Company feels this structure will allow it to raise non-toxic capital and giving it the means to start the uplist process, which is a goal of the Company’s to be completed by the end of 2018.

American Premium Water Corp is the publicly holding trading company that owns LALPINA HYDROGEN, LALPINA HYDROGEN CBD & Gents.

Please follow us on our social media outlets listed below:

@americanpremium
@lalpinabrands
@GentsCo
#Gentsco
#lalpinahydrogen

For more information on American Premium Water Corporation / HIPH, go to http://www.lalpinahydrogen.com/investor-page.html

Gents

The New York-based Gents is a producer of luxury hats and other fine accessories and apparel. Their line is carried in over 200 retail outlets internationally, including Bloomingdale’s, Nordstrom, and Saks Fifth Avenue.

Visit www.gentsco.com to learn more. https://www.gentsco.com

@GentsCo

#GentsCo

Safe Harbor Notice
Certain statements contained herein are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). American Premium Water Corporation cautions that statements made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates and assumptions made by management. Actual results could differ materially from current projections or implied results. American Premium Water Corporation undertakes no obligation to revise these statements following the date of this news release. Additional details of the Company's business can be found in its public disclosures as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC" EDGAR database.

This press release is issued on behalf of the Board of Directors by Alfred Culbreth, Founder /Director.

Disclaimer Regarding Forward Looking Statements

Certain statements in this press release, on American Premium Water Corporation’s (“APWC”) website and other oral and written statements made by APWC from time to time are “forward-looking statements”, as that term is defined in Section 27A of the United States Securities and Exchange Act of 1933, as amended, and Section 21E of the United States Securities and Exchange Act of 1934, as amended, Forward-looking statements include, without limitation, statements regarding beliefs, objectives, intentions, goals, plans, strategies, financial projections, any other statements regarding the future and any statements that are not purely historical. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors that may cause our actual results to differ materially from those expressed or implied by such forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Forward-looking statements speak only as of the date on which they are made, and APWC expressly disclaims any obligation to update or revise any forward-looking statements to reflect events or circumstances after the date thereof. All forward-looking statements, whether written or oral and whether made by or on behalf of the APWC, are expressly qualified by these cautionary statements. Forward-looking statements involve risks and uncertainties which could cause actual results or outcomes to differ materially from those expressed in the forward-looking statements. APWC’s expectations, beliefs and projections are expressed in good faith and are believed by the APWC to have a reasonable basis, but there can be no assurance that management's expectations, beliefs or projections will result or be achieved or accomplished. A variety of factors, many of which are beyond APWC’s control affect APWC’s operations, performance, business strategy and results and could cause the actual results, performance or achievements of APWC to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements. For APWC, particular uncertainties arise, amongst others but not limited to and not in any order of importance, from (i) focusing on and allocating more resources on certain target markets (ii) the possibility to raise further equity and debt to fund future growth, (iii) changes in demand for APWC’s products, (iv) performance issues with key suppliers, affiliates, agents, advisors or subcontractors, (v) changes in government changes in laws or regulations to which APWC or its suppliers are subject, including environmental laws and regulations relating to water or water sources and (vi) the inability to complete announced acquisitions, difficulty or unanticipated expenses in connection with integrating acquired businesses and the risk that anticipated synergies and opportunities as a result of acquisitions will not be realized or the risk that acquisitions do not perform as planned, including, for example, the risk that acquired businesses will not achieve revenue projections.

THIS NEWS RELEASE HAS BEEN PREPARED BY APWC’S MANAGEMENT, WHO TAKES FULL RESPONSIBILITY FOR ITS CONTENTS. NO SECURITIES REGULATORY AUTHORITY HAS APPROVED OR DISAPPROVED OF THE CONTENTS OF THIS NEWS RELEASE. THIS NEWS RELEASE SHALL NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY NOR SHALL THERE BE ANY SALE OF THESE SECURITIES IN ANY JURISDICTION IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL PRIOR TO REGISTRATION OR QUALIFICATION UNDER THE SECURITIES LAWS OF ANY SUCH JURISDICTION.

Contact Information:

American Premium Water Corporation
12777 Jefferson Blvd.
Suite 300
Playa Vista, CA 90066-7408
(888)-983-0054

Stock Symbol: HIPH
General Inquiries: info@americanpremiumwater.com
Investor Relations: ir@americanpremiumwater.com
Company Website: http://www.lalpinahydrogen.com/investor-page.html
Twitter: @americanpremium, @lalpinawater
Instagram: #lalpinahydrogen

Contact:
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 311

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 138

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 627

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 58

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 357

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 108

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 358

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 559

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading

Top 5 Most Recently Viewed Articles

Assessing TJX Companies Inc: Market Sentiment and Performance

Updated Category News Views 199

Understanding TJX Companies Inc's Market Dynamics TJX Companies Inc (NYSE: TJX) is currently navigating an intriguing landscape in the stock market, characterized by an increase in short interest. Notably, the short interest as a percentage of float has surged by 6.82% since the latest report, with approximately 15.68 million shares now sold short. This accounts for 1.41%...

Continue Reading
Refresco Teamsters Achieve Historic Contractual Victory

Updated Category News Views 337

Historic Contract Ratified by Teamsters Local 767 Members of Teamsters Local 767 have made headlines with their recent contract ratification that promises significant improvements for the workers of Refresco. An overwhelming majority of 93 percent voted in favor of this new agreement, showcasing the unity and commitment of the union members. Support for Employees The...

Continue Reading
MAP Medical and Metrix-Secure Team Up for Enhanced Healthcare

Updated Category News Views 133

MAP Medical Partners with Metrix-Secure for Enhanced Services MAP Medical has officially partnered with Metrix-Secure, a recognized leader in the medical supply industry. This collaboration empowers MAP Medical to serve as an authorized distributor, providing quality medical supply solutions to a wide array of healthcare facilities. Enhancing Patient Care with Reliable...

Continue Reading
Investors Show Interest in Unusual Options for Marriott

Updated Category News Views 153

Insights into Unusual Options Activity for Marriott International Recently, there has been a notable surge in bearish sentiment among investors concerning Marriott International (NASDAQ: MAR). This shift in attitude is essential for retail traders to understand as it may indicate changes in the market landscape. These trading patterns were identified through a publicly...

Continue Reading
Caribou Biosciences Investors Have Legal Avenues Available

Updated Category News Views 135

Opportunity for Investors of Caribou Biosciences For those who invested in Caribou Biosciences, Inc. (NASDAQ: CRBU), an exciting opportunity has emerged concerning potential legal claims. The Rosen Law Firm, recognized for its dedication to investor rights, is actively reminding purchasers of Caribou securities of their rights. If you bought securities between July 14,...

Continue Reading